Metrikler
Yayın
16
Açık Erişim
3
BM Sürdürülebilir Kalkınma Amaçları
Araştırma Alanları
Tıp
Dahili Tıp Bilimleri
İç Hastalıkları
Onkoloji
Sağlık Bilimleri
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (14)
SCI-E, SSCI, AHCI (14)
SCI-E, SSCI, AHCI, ESCI (14)
Scopus (12)
2025
20251. Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors
BAŞ O., Tokatli M., Savkliyildiz M., Yazarkan Y., Guduk N., Kilinc C., et al.
EXPERT REVIEW OF ANTICANCER THERAPY
, sa.4, ss.405-409, 2025 (SCI-Expanded)
2025
20252. Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience
BAŞ O., Tokatli M., Guduk N., Erdogan D., Boyraz N. E., Cengelci C., et al.
JOURNAL OF CLINICAL MEDICINE
, sa.8, 2025 (SCI-Expanded, Scopus)
2025
20253. Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer
BAŞ O., Guduk N., Tokatli M., Guven D. C., ÖZER N., ŞENER Y. Z., et al.
JOURNAL OF CLINICAL MEDICINE
, sa.5, 2025 (SCI-Expanded, Scopus)
2025
20254. The association between HALP score and survival in patients treated with immune checkpoint inhibitors
ŞAHİN T. K., GÜVEN D. C., Durukan M., BAŞ O., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF ANTICANCER THERAPY
, sa.1, ss.81-89, 2025 (SCI-Expanded)
2025
20255. Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
Majidova N., Arak H., ÖZALP F. R., BAŞ O., ÖZÇELİK KÖKER G., Ozmarasali E. B., et al.
SCIENTIFIC REPORTS
, sa.1, 2025 (SCI-Expanded, Scopus)
2024
20246. Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma
Demir T., Araz M., Moloney C., Hendem E., Kocak M. Z., ERMAN M., et al.
CLINICAL LUNG CANCER
, sa.7, 2024 (SCI-Expanded, Scopus)
2024
20247. Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study
KUTLU Y., Dae S. A., YILMAZ F., Erdem D., Sendur M. A. N., Akbas S., et al.
CANCERS
, cilt.16, sa.12, 2024 (SCI-Expanded, Scopus)
2022
20228. Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis
BAŞ O., Erul E., GÜVEN D. C., AKSOY S.
SUPPORTIVE CARE IN CANCER
, cilt.30, sa.11, ss.9071-9078, 2022 (SCI-Expanded, Scopus)
2022
20229. Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience
Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., TABAN H., et al.
FUTURE ONCOLOGY
, cilt.18, ss.323-331, 2022 (SCI-Expanded, Scopus)
2021
202110. Sarcopenia and anthracycline cardiotoxicity in patients with cancer
BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE
, 2021 (SCI-Expanded, Scopus)
2021
202111. Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report
GÜVEN D. C., KILIÇKAP S., YILDIRIM H. Ç., Ceylan F., BAŞ O., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.27, sa.5, ss.1281-1283, 2021 (SCI-Expanded, Scopus)
2021
202112. Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience
Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., Olgun P., et al.
CANCER RESEARCH
, cilt.81, sa.4, 2021 (SCI-Expanded, Scopus)
2020
202013. Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma
BAŞ O., Ozbek A., Guven D., Aktepe O., KILIÇ L., KERTMEN N., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.26, sa.5, ss.1230-1233, 2020 (SCI-Expanded, Scopus)
2019
201914. Classifying sarcopenia: using median value or cut-off values?
BAŞ O., DİZDAR Ö.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.176, sa.2, ss.479, 2019 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. Efficacy of systemic treatments in patients with metastatic lung invasive mucinous adenocarcinoma
Demir T., Araz M., Hendem E., Kocak M. Z., Erman M., Bas O., et al.
Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri)
2018
20182. GEBELİK ESNASINDA ORTAYA ÇIKAN GİTELMANSENDROMU
BAŞ O., ÇALIK BAŞARAN N., KÜKNER S., ÖZIŞIK L., ÖZ Ş. G., ARICI M.
20. Ulusal iç Hastalıkları Kongresi, Antalya, Türkiye, 10 - 14 Ekim 2018, (Özet Bildiri)